Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Shingles Health Center

Font Size

FDA Approves Horizant for Post-Shingles Pain

Drug Approved for Treatment of Postherpetic Neuralgia (PHN)
WebMD Health News
Reviewed by Laura J. Martin, MD

June 8, 2012 -- The FDA has approved a drug currently used for restless leg syndrome to treat a common and painful complication of shingles, according to the medication's manufacturers.

Horizant (gabapentin enacarbil) has been approved to treat postherpetic neuralgia (PHN) in adults.

PHN is a painful syndrome that can lead to disability in some people. It occurs after an outbreak of herpes zoster, more commonly known as shingles.

Researchers say about 1 million people in the U.S. develop shingles each year. Of these, about 10% will go on to develop PHN.

PHN causes pain in the area affected by shingles, often in the torso, and can last for months or even years after the initial infection.

New Use for Drug

Horizant was approved in 2011 to treat restless leg syndrome.

In approving Horizant to treat PHN, the FDA evaluated the safety and effectiveness of the drug in three clinical trials involving 574 people.

Researchers don't know exactly how Horizant works to reduce PHN-associated symptoms, but studies have shown that gabapentin can help relieve nerve-related pain.

The most common side effects of Horizant are dizziness, sleepiness, and headaches.

The drug may also impair a person's ability to drive a car. People taking Horizant should not drive a car or operate heavy machinery until they have enough experience with the drug to determine whether their driving ability is affected.

Horizant is a slightly less active form of the antiepileptic drug gabapentin. This type of antiepileptic drug increases the risk of suicidal thoughts and behaviors.

Horizant also increases these risks, and people taking the drug should talk to their health care provider about any new or worsening depression or suicidal thoughts.

The drug was developed by XenoPort Inc. and is marketed by GlaxoSmithKline.

Today on WebMD

varicella zoster virus
How to recognize this painful rash.
shingles rash
Symptoms, causes, and treatment.
nurse administering flu vaccine
8 questions, answered.
senior woman
Are you more likely to get it?
shingles rash
woman holding her lower back
New PHN Drug Cuts Lingering Shingles Pain
mature man with serious expression